Cargando…

Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral Center

SIMPLE SUMMARY: Jaundice is a common clinical presentation of cholangiocarcinoma; however, the prognostic impact of this symptom is poorly understood. We retrospectively analyzed all consecutive cases presenting with jaundice between January 2010 and December 2017. During the study period, 200 patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lleo, Ana, Colapietro, Francesca, Maisonneuve, Patrick, Aloise, Monia, Craviotto, Vincenzo, Ceriani, Roberto, Rimassa, Lorenza, Badalamenti, Salvatore, Donadon, Matteo, Pedicini, Vittorio, Repici, Alessandro, Di Tommaso, Luca, Voza, Antonio, Torzilli, Guido, Aghemo, Alessio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123266/ https://www.ncbi.nlm.nih.gov/pubmed/33922972 http://dx.doi.org/10.3390/cancers13092070

Ejemplares similares

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization
por: Masetti, Chiara, et al.
Publicado: (2022)

Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)
por: Comito, Tiziana, et al.
Publicado: (2022)

Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
por: Lanza, Ezio, et al.
Publicado: (2020)

Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
por: Lanza, Ezio, et al.
Publicado: (2020)

Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study
por: Viganò, Luca, et al.
Publicado: (2022)

Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients
por: Milana, Flavio, et al.
Publicado: (2022)

The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy()
por: Desai, Antonio, et al.
Publicado: (2021)

Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life
por: Pugliese, Nicola, et al.
Publicado: (2023)

Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization
por: Lanza, Ezio, et al.
Publicado: (2020)

Prognostic Value of Metabolic Imaging Data of (11)C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
por: Donadon, Matteo, et al.
Publicado: (2021)

Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
por: Personeni, Nicola, et al.
Publicado: (2020)

The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment
por: Macias, Rocio I. R., et al.
Publicado: (2023)

The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors
por: Donadon, Matteo, et al.
Publicado: (2018)

Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells
por: Polidoro, Michela Anna, et al.
Publicado: (2020)

Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence
por: Milana, Flavio, et al.
Publicado: (2023)

Role of liver biopsy in hepatocellular carcinoma
por: Di Tommaso, Luca, et al.
Publicado: (2019)

Obstructive Jaundice in Polycystic Liver Disease Related to Coexisting Cholangiocarcinoma
por: Delis, Spiros G., et al.
Publicado: (2008)

COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy
por: Aghemo, Alessio, et al.
Publicado: (2020)

Impact of Oocyte Extract Supplement on Quality of Life after Hepatectomy for Liver Tumours: A Prospective, Multicentre, Double-Blind Randomized Clinical Trial
por: Donadon, Matteo, et al.
Publicado: (2023)

Reversal of Jaundice in Two Patients with Inoperable Cholangiocarcinoma Treated with Cisplatin and Gemcitabine Combination
por: Criel, Maarten, et al.
Publicado: (2012)

A rare case report of obstructive jaundice caused by mucus-producing cholangiocarcinoma
por: Duan, Botao, et al.
Publicado: (2022)

Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations
por: Vespa, Edoardo, et al.
Publicado: (2021)

Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients
por: Colapietro, Francesca, et al.
Publicado: (2023)

Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
por: Malenica, Ines, et al.
Publicado: (2020)

Antimitochondrial Antibodies: from Bench to Bedside
por: Colapietro, Francesca, et al.
Publicado: (2021)

An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study
por: Laino, Maria Elena, et al.
Publicado: (2022)

Surgery for cholangiocarcinoma
por: Cillo, Umberto, et al.
Publicado: (2019)

PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales
por: Colapietro, Francesca, et al.
Publicado: (2023)

A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives
por: Torzilli, Guido, et al.
Publicado: (2020)

Disseminated Carcinomatosis of Bone Marrow as the Initial Presentation of Intrahepatic Cholangiocarcinoma without Jaundice: An Autopsy Case Report
por: Okumura, Taiki, et al.
Publicado: (2021)

Role of molecular genetics in the clinical management of cholangiocarcinoma
por: Normanno, N., et al.
Publicado: (2022)

MICA/B-targeted antibody promotes NK cell–driven tumor immunity in patients with intrahepatic cholangiocarcinoma
por: Oliviero, Barbara, et al.
Publicado: (2022)

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Famularo, Simone, et al.
Publicado: (2023)

Novel Therapies for Hepatocellular Carcinoma
por: Rimassa, Lorenza
Publicado: (2020)

Jaundice
Publicado: (1860)

Addition of Molecular Adsorbent Recirculating System (MARS(®)) Albumin Dialysis for the Preoperative Management of Jaundiced Patients with Hilar Cholangiocarcinoma
por: Regimbeau, Jean-Marc, et al.
Publicado: (2013)

A New Surgical Procedure “Dumbbell-Form Resection” for Selected Hilar Cholangiocarcinomas With Severe Jaundice: Comparison With Hemihepatectomy
por: Wang, Shuguang, et al.
Publicado: (2016)

Effect of postoperative early enteral nutrition on clinical outcomes and immune function of cholangiocarcinoma patients with malignant obstructive jaundice
por: Ma, Bing-Qiang, et al.
Publicado: (2020)

The effect of COVID-19 epidemic on vital signs in hospitalized patients: a pre-post heat-map study from a large teaching hospital
por: Caruso, Pier Francesco, et al.
Publicado: (2021)

New patients to the Leeds spondyloarthritis clinic: is referral stratification working?
por: Thomas, Rebecca C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rlss3m0deqv3dcjmu4p627t1vm